CRY - CryoLife, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.13B
Enterprise Value 31.33B
Trailing P/E 1,586.32
Forward P/E 168.50
PEG Ratio (5 yr expected) 13.38
Price/Sales (ttm)4.19
Price/Book (mrq)4.12
Enterprise Value/Revenue 34.95
Enterprise Value/EBITDA 640.09

Trading Information

Stock Price History

Beta (3Y Monthly) 0.69
52-Week Change 3-2.05%
S&P500 52-Week Change 36.04%
52 Week High 336.05
52 Week Low 323.99
50-Day Moving Average 329.87
200-Day Moving Average 329.23

Share Statistics

Avg Vol (3 month) 3186.61k
Avg Vol (10 day) 3155.52k
Shares Outstanding 537.34M
Float 35.72M
% Held by Insiders 13.82%
% Held by Institutions 172.14%
Shares Short (Jun 28, 2019) 4486.83k
Short Ratio (Jun 28, 2019) 42.28
Short % of Float (Jun 28, 2019) 41.60%
Short % of Shares Outstanding (Jun 28, 2019) 41.30%
Shares Short (prior month May 31, 2019) 4375.83k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.03
Trailing Annual Dividend Yield 30.10%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 18, 2015
Ex-Dividend Date 4Dec 9, 2015
Last Split Factor (new per old) 22/3
Last Split Date 3Dec 28, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.27%
Operating Margin (ttm)6.08%

Management Effectiveness

Return on Assets (ttm)1.74%
Return on Equity (ttm)0.26%

Income Statement

Revenue (ttm)268.4M
Revenue Per Share (ttm)7.34
Quarterly Revenue Growth (yoy)9.00%
Gross Profit (ttm)175.78M
EBITDA 33.18M
Net Income Avi to Common (ttm)709k
Diluted EPS (ttm)0.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.34M
Total Cash Per Share (mrq)1.08
Total Debt (mrq)247.66M
Total Debt/Equity (mrq)90.85
Current Ratio (mrq)4.91
Book Value Per Share (mrq)7.31

Cash Flow Statement

Operating Cash Flow (ttm)20.77M
Levered Free Cash Flow (ttm)20.68M